Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Portero

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Medicina Clinica|November 21, 1992
[Prognostic effect of beta 2-microglobulin in multiple myeloma]F Ortega, M González, M J Moro, et al.
Sangre|January 1, 1983
[The importance of terminal deoxyribonucleotidyl transferase in myeloblastic leukemias. Apropos of 2 cases]J F San Miguel, J A Portero, M Gonzaĺez, et al.
Sangre|June 1, 1992
[Utility of the examination of plasma-cell morphology in the study of multiple myeloma]M J Moro, J A Portero, A Gascón, et al.
Haematologica|December 1, 2001
Fluorescence in situ hybridization study of TEL/AML1 fusion and other abnormalities involving TEL and AML1 genes. Correlation with cytogenetic findings and prognostic value in children with acute lymphocytic leukemiaA Martínez-Ramírez, M Urioste, T Contra, et al.
British Journal of Haematology|April 1, 1996
Analysis of natural killer-associated antigens in peripheral blood and bone marrow of multiple myeloma patients and prognostic implicationsR García-Sanz, M González, A Orfão, et al.
International Journal of Cancer|September 24, 2004
Proliferative activity of plasma cells is the most relevant prognostic factor in elderly multiple myeloma patientsR García-Sanz, M I González-Fraile, G Mateo, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Medicina Clinica|November 21, 1992
[Prognostic effect of beta 2-microglobulin in multiple myeloma]F Ortega, M González, M J Moro, et al.
Sangre|January 1, 1983
[The importance of terminal deoxyribonucleotidyl transferase in myeloblastic leukemias. Apropos of 2 cases]J F San Miguel, J A Portero, M Gonzaĺez, et al.
Sangre|June 1, 1992
[Utility of the examination of plasma-cell morphology in the study of multiple myeloma]M J Moro, J A Portero, A Gascón, et al.
Haematologica|December 1, 2001
Fluorescence in situ hybridization study of TEL/AML1 fusion and other abnormalities involving TEL and AML1 genes. Correlation with cytogenetic findings and prognostic value in children with acute lymphocytic leukemiaA Martínez-Ramírez, M Urioste, T Contra, et al.
British Journal of Haematology|April 1, 1996
Analysis of natural killer-associated antigens in peripheral blood and bone marrow of multiple myeloma patients and prognostic implicationsR García-Sanz, M González, A Orfão, et al.
International Journal of Cancer|September 24, 2004
Proliferative activity of plasma cells is the most relevant prognostic factor in elderly multiple myeloma patientsR García-Sanz, M I González-Fraile, G Mateo, et al.
Pageof 2